ANNALS OF SURGICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2021-03-26 六公子

审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0
偏重的研究方向：胸外科;肿瘤学;肺癌
经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。

71 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2021-05-23 14617db6m31暂无昵称

所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么

96 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2021-06-04 12200887m48(暂无昵称)

审稿速度:1.0 | 投稿命中率:50.0
经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。

78 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2022-10-11 0春夏秋冬0

想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！

65 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2022-02-12 ms2000001633593819

偏重的研究方向：prostate cancer
经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2023-05-22 新来的小李来自四川省

审稿速度:1.0
偏重的研究方向：肿瘤;胸外科
经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。

76 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2020-01-19 wangzilk

审稿速度:1.0 | 投稿命中率:25.0
经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！

218 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2020-09-29 mkong82

审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0
偏重的研究方向：胃肠外科;肿瘤
经验分享：贴两个今年投稿的status，其中第二个还在返修中。
1#
2020-7-28 submitted
30-Jul-2020 Under Review
14-Aug-2020 Reject

2#
16-Aug-2020 submitted
17-Aug-2020 Under Review
25-Aug-2020 Major Revision with No Acceptance Implied

142 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2024-01-23 新来的小李来自云南省

偏重的研究方向：肿瘤学;外科
经验分享：第二次投稿到接收50天左右，感觉很不错

34 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=951375, encodeId=b4a39513e5e7, content=审稿速度:1.0 | 投稿命中率:95.0 | 审稿费用:50.0 | 版面费用:100.0 偏重的研究方向：胸外科;肿瘤学;肺癌 经验分享：去年十一月底投稿，今年一月初收到major revision的decision letter，给了11条非常中肯的意见，花了20天修改resubmit后过了一月收到minor revision的decision letter，给了两条意见，花了10天修改提交后只过了8天就再次收到了minor revision的decision letter，又提了两条意见，花了9天再次修改提交后，只过了4天就accept了。这是我第一次投SCI，前后经历了一次大修，两次小修，一共花了三月多不到四月的时间。杂志审稿非常迅速，给编辑发的邮件回复得也很及时，reviewer每次的意见也非常中肯，没有版面费，accept后还被邀请写Author Reflections，非常好的一本杂志。非常有收获和愉快的一次投稿经历。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/23/3d12259d3d39e7fcfecf6d6df24de45a.jpg, createdBy=72c62363340, createdName=六公子, createdTime=Fri Mar 26 13:15:36 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明（Disclosure form），但是为啥还是显示Awaiting disclosure form，有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970925, encodeId=97b29e0925bc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：胸部肿瘤临床文章 4.17投稿 5.5意见返回来（小修） 5.17投回去 6.2接收，还邀请写作者点评。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68d02298711, createdName=12200887m48(暂无昵称), createdTime=Fri Jun 04 17:18:50 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬，我目前已缴费，已让所有作者提交了披露声明，一周了，还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向：prostate cancer 经验分享：请教一下各位：投稿后第二个EO已经under review 1个月了，还是没有到外审，要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0 偏重的研究方向：肿瘤;胸外科 经验分享：很快，审稿人意见很专业，一审1个月多一点，大修，两个审稿人提了10条意见，返修后二审20天，accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.16号投稿，投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889215, encodeId=7b2788921583, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:50.0 偏重的研究方向：胃肠外科;肿瘤 经验分享：贴两个今年投稿的status，其中第二个还在返修中。 1# 2020-7-28 submitted 30-Jul-2020 Under Review 14-Aug-2020 Reject 2# 16-Aug-2020 submitted 17-Aug-2020 Under Review 25-Aug-2020 Major Revision with No Acceptance Implied, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=mkong82, createdTime=Tue Sep 29 15:00:04 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向：肿瘤学;外科 经验分享：第二次投稿到接收50天左右，感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=810718, encodeId=79fb810e1888, content=请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Aug 19 15:06:22 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2020-08-19 牵牛花开

请问各位大侠，我投稿成功后就出现了两个编辑的名字，下面就有“Under Review”,但是“Under Review”前面的按钮是灰色的，请问大家伙知道这个是已经送外审了吗？

139 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务